1. Home
  2. Stock quotes
  3. Supernus Pharmaceuticals
  4. Financial Ratios
  5. EV/EBITDA Ratio
Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 35.94 -2.63%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Supernus Pharmaceuticals EV/EBITDA Ratio 2011-2025 | SUPN

Annual EV/EBITDA Ratio Supernus Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
19.1 8.48 8.97 13.6 18 21.1 27.5 13.9 -5.12 -2.83 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
27.5 -5.12 12.3